Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities.
Shoskes
D A
DA
Department of Urology, Cleveland Clinic Florida, Weston, Florida, USA. dshoskes@mac.com
Thomas
M
M
Pobgee
R
R
Fromkin
B
B
Copley
J B
JB
D000284:Administration, Oral; D065095:Calcineurin Inhibitors; D003404:Creatinine / Q000097:blood; D005419:Flavonoids / Q000008:administration & dosage / Q000009:adverse effects*; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D016030:Kidney Transplantation / Q000473:pathology / Q000502:physiology*; D013997:Time Factors; D014019:Tissue Donors
D065095:Calcineurin Inhibitors; D005419:Flavonoids; D003404:Creatinine